# FDA Inspection 1161167 - CFP Acquisitions Inc. - January 18, 2022

Source: https://www.keypedia.com/records/fda_inspections/cfp-acquisitions-inc/986dba68-3cfb-450f-8bb3-9d8ed192e56f
Source feed: FDA_Inspections

> FDA Inspection 1161167 for CFP Acquisitions Inc. on January 18, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1161167
- Company Name: CFP Acquisitions Inc.
- Inspection Date: 2022-01-18
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1058647 - 2018-07-11](https://www.keypedia.com/records/fda_inspections/cfp-acquisitions-inc/205c686d-09c8-4ecf-b2b4-c7249057d72e)
- [FDA Inspection 917724 - 2015-03-13](https://www.keypedia.com/records/fda_inspections/cfp-acquisitions-inc/c05258db-e9f7-4cc4-9819-7400b5cfcf21)

Company: https://www.keypedia.com/companies/cfp-acquisitions-inc/27cf9a06-4a99-40fd-adff-e6ca4e741871

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c